Press Releases for GTF (NYSE)
|
|
2010 |
|
Mar 04 |
|
Cytomedix To Host Fourth Quarter and Year End 2009 Financial Results
Conference Call On Tuesday, March 30, 2010 |
|
2010 |
|
Feb 23 |
|
Cytomedix’s AutoloGel™ System Highlighted in Hair Transplant Trade Journal |
|
2009 |
|
Nov 13 |
|
Cytomedix Appoints Dr. Craig Mendelsohn to Board of Directors |
|
2009 |
|
Nov 11 |
|
Cytomedix Reports Third Quarter Financial Results |
|
2009 |
|
Oct 30 |
|
Cytomedix To Host Third Quarter And Nine Months 2009 Financial Results Conference Call On Thursday, November 12, 2009 |
|
2009 |
|
Oct 27 |
|
Cytomedix to Present at the 8th Annual BIO Investor Forum |
|
2009 |
|
Oct 15 |
|
Cytomedix to Present at Growth Stock Conference Hosted by Security Research Associates, Inc. |
|
2009 |
|
Sept 30 |
|
Cytomedix Enters License Agreement with Millennia Holdings for Exclusive
Rights to the Autologel System in Japan |
|
2009 |
|
Sept 9 |
|
Cytomedix CEO Issues Shareholder Update |
|
2009 |
|
Aug 27 |
|
Cytomedix Announces Subsequent and Final Closing of Registered Direct
Offering of Common Stock and Warrants |
|
2009 |
|
Aug 25 |
|
Cytomedix Announces Registered Direct Offering of
Common Stock and Warrants |
|
2009 |
|
Aug 10 |
|
Cytomedix Second Quarter Financial Results Feature
Product Sales Up 72% Over First Quarter |
|
2009 |
|
Aug 7 |
|
Cytomedix Files Application with FDA for AutoloGel™
System in Orthopedics |
|
2009 |
|
Jul 29 |
|
Cytomedix Announces Acceptance by NYSE Amex of Plan of Compliance |
|
2009 |
|
May 27 |
|
Cytomedix Announces the Publication of a New AutoloGel™
Case Series in the Journal Wounds |
|
2009 |
|
May 15 |
|
Cytomedix Receives a NYSE Amex Listing Deficiency Notification |
|
2009 |
|
Apr 23 |
|
Cytomedix To Exhibit at the 22nd Annual Sympsosium on
Advanced Wound Care and Wound Healing Society (SAWC/WHS) Meeting |
|
2009 |
|
Apr 09 |
|
Cytomedix CEO Discusses the Company and his Leadership
Style in an Interview on the Leaders Spot with Rebecca Blacksmith |
|
2009 |
|
Mar 31 |
|
Cytomedix, Inc. Reports Year-End 2008 Financial Results |
|
2009 |
|
Mar 31 |
|
Cytomedix CEO Issues Shareholder Update |
|
2009 |
|
Feb 05 |
|
Cytomedix Further Strengthens Its Board of Directors |
|
2008 |
|
Dec
10 |
|
Cytomedix Announces Publication of Economic Model Indicating
Cost-Effectiveness of AutoloGel™ for Diabetic Foot Ulcers |
|
2008 |
|
Oct
20 |
|
Cytomedix
To Present At Rodman & Renshaw 10TH Annual Healthcare Conference
On Wednesday, Nov. 12, 2008 |
|
2008 |
|
Sep
19 |
|
Cytomedix
On Track With Sales and Marketing Efforts For AutoloGel™ System and Further
Development of CT-112 Peptide, Annual Meeting Told |
|
2008 |
|
Sep
10 |
|
Cytomedix
Appoints Dr. Peter A. Clausen as Vice President of Business Development |
|
2008 |
|
Sep
08 |
|
Cytomedix
Completes $1.5 Million Capital Raise |
|
2008 |
|
Aug
19 |
|
Cytomedix
CEO Martin Rosendale Discusses Company in Interview with the Wall Street
Transcript |
|
|
|
|
|
The Wall Street Transcript -
August 18, 2008 |
|
2008 |
|
Jul
28 |
|
Cytomedix
Retains Dr. David F. Counts, Inventor of Company's Anti-Inflammatory Peptide
Patent |
|
2008 |
|
Jul
16 |
|
Cytomedix
CEO Issues Shareholder Update |
|
2008 |
|
Jun
12 |
|
Cytomedix
Unveils Clinical Plans for the Development of Anti-Inflammatory Peptides |
|
2008 |
|
Jun
09 |
|
Cytomedix Announces Transition of Leadership
Martin Rosendale Appointed CEO |
|
2008 |
|
May
14 |
|
Cytomedix Joins
The Acute Long Term Hospital Association (ALTHA) as an Allied Member |
|
2008 |
|
May
05 |
|
Cytomedix Gains Access To U.S. Government Medical Facilities By Adding The
AutoloGel™ System To The Federal Supply Schedule |
|
2008 |
|
Apr
22 |
|
Cytomedix Provides Update on Efforts to Secure
Medicare Reimbursement for Its AutoloGel™ System |
|
2008 |
|
Apr
10 |
|
Cytomedix to Exhibit at the 21ST Annaul Symposium On
Advanced Wound Care (SAWC) April 24-27, 2008 |
|
2008 |
|
Mar
19 |
|
Centers For Medicare And Medicaid Services (CMS)
Reaches Final Coverage Decision on PRP GEL |
|
2008 |
|
Mar
17 |
|
Cytomedix Appoints Martin P. Rosendale Executive Vice
President and Chief Operating Officer |
|
2008 |
|
Feb
12 |
|
The Kon-Lin Letter Initiates New Coverage of Cytomedix In Its February 2008
Issue With Initial Target of $4.50-$5.00 and Ultimate Target of $7-$9 |
|
2008 |
|
Jan
30 |
|
Cytomedix Submits Comments in Response to CMS’ Proposed National Coverage
Decision |
|
2007 |
|
Dec
21 |
|
Cytomedix Announces That CMS Preliminary Affirms Non-Coverage of PRP Gel |
|
2007 |
|
Dec
04 |
|
Cytomedix Files Registration Statement |
|
2007 |
|
Nov
07 |
|
Cytomedix To Restate Previously Issued Financial
Statements For Stock-Option Related Compensation |
|
2007 |
|
Oct
16 |
|
Cytomedix Licenses Technology To Smith & Nephew |
|
2007 |
|
Oct
12 |
|
Cytomedix Issues Warrant Call |
|
2007 |
|
Oct
08 |
|
Cytomedix Submits Cost Effectiveness Study for AutoloGel™ to CMS |
|
2007 |
|
Aug
23 |
|
Cytomedix Announces Its Outside Patent Counsel Agrees to Take Equity Stake
in the Company |
|
2006 |
|
Oct
09 |
|
Cytomedix Appoints David A. Hotchkiss as Vice President for Sales and
Marketing |
|
2006 |
|
Aug
23 |
|
Cytomedix Autologel™ Clinical Trial Presentation Receives Top Award at APMA
Annual Meeting |
|
2006 |
|
Aug
09 |
|
Cytomedix Announces Second Quarter 2006 Financial Results |
|
2006 |
|
Aug
02 |
|
Cytomedix Issues Warrant Call |
|
2006 |
|
July
05 |
|
Cytomedix Joins New Russell Microcap Index |
|
2006 |
|
Jun
28 |
|
Cytomedix Announces Publication of the Autologel Diabetic Foot Ulcer
Prospective Trial |
|
2006 |
|
May
22 |
|
Cytomedix Licenses Patents To BIOMET For $2.6 Million |
|
2006 |
|
May
01 |
|
Cytomedix To Receive $2.2 Million From Existing Warrantholders |
|
2006 |
|
Jan
24 |
|
CYTOMEDIX ANNOUNCES AVAILABILITY OF RESEARCH REPORT ON
COMPANY |
